PainChek Limited (PCK.XA)
Cboe AU · AUD
A$0.07 (+0.00%) as of
Key statistics
- EPS (TTM)
- -0.0060
- 52-week range
- 0.0700 – 0.5000
- Beta
- 0.47
- Revenue (TTM)
- 3.74M
- Profit margin
- -238.78%
- Volume
- 152.41k
About PainChek Limited
PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
- Headquarters
- Sydney, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.